This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza
Trial details
- Registry ID
- NCT07371650
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate InfluenzaNCT07371650 | TRAW | Phase 2 | Active not recruiting | 2026-12Estimated |
| Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge ModelNCT07503405 | TRAW | Phase 2 | Not yet recruiting | 2026-11Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |